Telomeres and human disease: ageing, cancer and beyond.

Authors:
Maria A Blasco

Nat Rev Genet 2005 Aug;6(8):611-22

Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain.

Telomere length and telomerase activity are important factors in the pathobiology of human disease. Age-related diseases and premature ageing syndromes are characterized by short telomeres, which can compromise cell viability, whereas tumour cells can prevent telomere loss by aberrantly upregulating telomerase. Altered functioning of both telomerase and telomere-interacting proteins is present in some human premature ageing syndromes and in cancer, and recent findings indicate that alterations that affect telomeres at the level of chromatin structure might also have a role in human disease. These findings have inspired a number of potential therapeutic strategies that are based on telomerase and telomeres.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrg1656DOI Listing
August 2005
1 Read

Publication Analysis

Top Keywords

human disease
12
premature ageing
8
ageing syndromes
8
functioning telomerase
4
altered functioning
4
telomerase telomere-interacting
4
telomere-interacting proteins
4
syndromes cancer
4
human premature
4
proteins human
4
telomerase altered
4
upregulating telomerase
4
cells prevent
4
tumour cells
4
viability tumour
4
prevent telomere
4
telomeres
4
aberrantly upregulating
4
loss aberrantly
4
cancer findings
4

References

(Supplied by CrossRef)

T De Lange et al.
Oncogene 2002

EH Blackburn et al.
Cell 2001

K Collins et al.
Oncogene 2002

JD Griffith et al.
Cell 1999

T Nikitina et al.
J. Cell Biol. 2004

T De Lange et al.
Nature Rev. Mol. Cell Biol. 2004

H Tommerup et al.
Mol. Cell. Biol. 1994

M Garcia Cao et al.
Nature Genet. 2004

S Gonzalo et al.
Nature Cell Biol. 2005

AH Peters et al.
Cell 2001

G Schotta et al.
Genes Dev. 2004

Similar Publications